Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 16, 2024 07:19 ET
|
Anika Therapeutics Inc.
BEDFORD, Mass., July 16, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that on July 1,...
Anika Announces Full Market Release of the Integrity™ Implant System, a Regenerative Hyaluronic Acid-Based Scaffold for Rotator Cuff and Other Tendon Repairs
July 11, 2024 08:30 ET
|
Anika Therapeutics Inc.
Integrity and its complete arthroscopic instrumentation platform are now fully available in the U.S., expanding Anika’s proprietary hyaluronic acid (HA) regenerative portfolio Over 300 surgeries...
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 07, 2024 16:01 ET
|
Anika Therapeutics Inc.
BEDFORD, Mass., June 07, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that on June 3,...
Anika Enters into Cooperation Agreement with Caligan Partners
May 28, 2024 16:05 ET
|
Anika Therapeutics Inc.
Appoints Joseph Capper and William Jellison to Board of DirectorsAnnounces New $40 Million Share Repurchase Program BEDFORD, Mass., May 28, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc....
Anika Announces CFO Transition
May 08, 2024 16:08 ET
|
Anika Therapeutics Inc.
BEDFORD, Mass., May 08, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that it has appointed...
Anika Reports First Quarter 2024 Financial Results
May 08, 2024 16:05 ET
|
Anika Therapeutics Inc.
Revenue up 7% on growing demand and favorable order timing; On-track for 2024 revenue guidance Cost reduction initiatives complete; On-track to achieve 2024 adjusted EBITDA guidance of $25-30...
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 03, 2024 16:01 ET
|
Anika Therapeutics Inc.
BEDFORD, Mass., May 03, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that on May 1, 2024,...
Anika to Issue First Quarter 2024 Financial Results on Wednesday, May 8, 2024
April 18, 2024 16:01 ET
|
Anika Therapeutics Inc.
BEDFORD, Mass., April 18, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that the Company...
Anika to Participate in the 23rd Annual Needham Virtual Healthcare Conference
April 02, 2024 08:00 ET
|
Anika Therapeutics Inc.
BEDFORD, Mass., April 02, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that management...
Anika Reports Fourth Quarter and Year-End 2023 Financial Results
March 13, 2024 16:05 ET
|
Anika Therapeutics Inc.
Revenue growth and adjusted EBITDA1 exceeded expectations in the fourth quarter and full year OA Pain Management achieved record annual revenues of $102 million, up 11% in 2023 Announces cost...